Ben Zimmerman

Ben Zimmerman currently serves as the Head of Global Forecasting and Business Analytics at Genmab, focusing on global forecasting and analytics within oncology, hematology, immunology, and inflammation. Prior to this role, Ben held several positions at Bristol Myers Squibb, including Senior Director of International Market Insights & Capabilities, where leadership extended to teams in the UK, Switzerland, and India, concentrating on commercial revenue forecasting and market research across a diverse portfolio. Ben also served as Director of Oncology Strategic Planning & Forecasting, overseeing worldwide oncology commercialization, and as Associate Director, focusing on forecasting for key oncology assets. Earlier experience includes a role as Business Consulting Manager at ZS Associates, engaged in projects related to forecasting, analytics, and market research. Ben earned a BA in Physics from the University of Chicago.